World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
44
Citations
9506
World Ranking
19232
National Ranking
7859

Overview

Yupo Ma is a researcher affiliated with Stony Brook University in the United States. Their primary fields of study are Medicine and Immunology and Microbiology, with significant contributions to subfields including Immunology, Oncology, Genetics, Physiology, and Molecular Biology.

The research focus of Yupo Ma covers multiple topics, notably:

  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Virus-based gene therapy research
  • T-cell and B-cell Immunology
  • Cancer Immunotherapy and Biomarkers
  • Immune cells in cancer
  • Systemic Lupus Erythematosus Research

Yupo Ma has contributed to various recent publications, including:

  • "Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer" (2021, Cancer Letters)
  • "BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial" (2024, Annals of the Rheumatic Diseases)
  • "Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti-CD5 CAR T Cells" (2021, Stem Cell Reviews and Reports)
  • "Treatment of Systemic Lupus Erythematosus using BCMA-CD19 Compound CAR" (2021, Stem Cell Reviews and Reports)
  • "Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells" (2021, Pharmacological Research)

The most frequent publication venues where Yupo Ma's work has appeared include:

  • Stem Cell Reviews and Reports
  • Annals of the Rheumatic Diseases
  • Frontiers in Immunology
  • Cancer Letters
  • Pharmacological Research

Frequent collaborators in Yupo Ma's research network are:

  • M. Wada
  • Kevin G. Pinz
  • Wenli Zhang
  • Jia Feng
  • Hongyu Zhang

Best Publications

  • Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1.

    Jinqiu Zhang;Wai-Leong Tam;Wai-Leong Tam;Guo Qing Tong;Qiang Wu

  • Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties

    Elaine Lai-Han Leung;Ronald R. Fiscus;Ronald R. Fiscus;James W. Tung;Vicky Pui-Chi Tin

  • Phenotypic correction of murine hemophilia A using an iPS cell-based therapy

    Dan Xu;Zaida Alipio;Louis M. Fink;Dorothy M. Adcock

  • SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice

    Yupo Ma;Wei Cui;Jianchang Yang;Jun Qu

  • Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma.

    Hesham M Amin;Timothy J McDonnell;Yupo Ma;Quan Lin

  • Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells

    Jianchang Yang;Li Chai;Taylor C. Fowles;Zaida Alipio

  • A Novel SALL4/OCT4 Transcriptional Feedback Network for Pluripotency of Embryonic Stem Cells

    Jianchang Yang;Chong Gao;Li Chai;Yupo Ma

  • Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells.

    Jianchang Yang;Li Chai;Fang Liu;Louis M. Fink

  • Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor

    K. H. Chen;M. Wada;K. G. Pinz;H. Liu

  • Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts.

    Hui Gai;Elaine Lai-Han Leung;Peter D. Costantino;Jerell R. Aguila

  • SALL4 is a key regulator of survival and apoptosis in human leukemic cells

    Jianchang Yang;Li Chai;Chong Gao;Taylor C. Fowles

  • Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma.

    Hesham M Amin;L Jeffrey Medeiros;Yupo Ma;Marianna Feretzaki

  • Circulating Tumor Cells in Patients with Castration-Resistant Prostate Cancer Baseline Values and Correlation with Prognostic Factors

    Oscar B. Goodman;Louis M. Fink;James T. Symanowski;Bryan Wong

  • Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer.

    Ze-Bo Jiang;Wen-Jun Wang;Cong Xu;Ya-Jia Xie

  • In Vivo Cardiac Cellular Reprogramming Efficacy Is Enhanced by Angiogenic Preconditioning of the Infarcted Myocardium With Vascular Endothelial Growth Factor

    Megumi Mathison;Robert P. Gersch;Ahmed Nasser;Sarit Lilo

  • BRCA1 is a negative modulator of the PRC2 complex

    Lan Wang;Xianzhuo Zeng;Shuai Chen;Liya Ding

  • CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS OF USE THEREOF

    Yupo Ma;Kevin Pinz;Xun Jiang;Masayuki Wada

  • SALL4 is a robust stimulator for the expansion of hematopoietic stem cells

    Jerell R. Aguila;Wenbin Liao;Jianchang Yang;Cecilia Avila

  • First-in-Human CLL1-CD33 Compound CAR T Cell Therapy Induces Complete Remission in Patients with Refractory Acute Myeloid Leukemia: Update on Phase 1 Clinical Trial

    Fang Liu;Yuanzhen Cao;Kevin Pinz;Yu Ma

  • Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies.

    Kevin H. Chen;Masayuki Wada;Amelia E. Firor;Kevin G. Pinz

Frequent Co-Authors

Raymond Lai
Raymond Lai University of Alberta
Yu Zhang
Yu Zhang Peking University
Xinxin Ding
Xinxin Ding University of Arizona
David C. Ward
David C. Ward Nevada Cancer Research Foundation
Nicholas J. Vogelzang
Nicholas J. Vogelzang University of Nevada Reno
Leslie E. Silberstein
Leslie E. Silberstein Boston Children's Hospital
Thomas L. Benjamin
Thomas L. Benjamin Harvard University
Bing Lim
Bing Lim Thymmune Therapeutics
Huck-Hui Ng
Huck-Hui Ng Genome Institute of Singapore
Haifa Shen
Haifa Shen Houston Methodist

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry opens doors to a wide range of interdisciplinary career options. In the USA, many professionals choose to further their studies online, helping them balance work and education.

For those interested in the pharmaceutical sector, pharm d online programs offer a flexible route to earn an advanced degree and qualify for rewarding pharmacy careers. If applying biological principles to fitness and health sparks your interest, pursuing an exercise science and nutrition degree online could lead to opportunities in wellness, sports science, or allied health fields.

Those passionate about physical movement and rehabilitation may find kinesiology online programs to be a strong match, enabling careers in coaching, therapy, and research. For an accelerated path in mental health nursing, students can consider a 1 year pmhnp program online and step into much-needed psychiatric nurse practitioner roles.

Overall, online degrees offer flexibility and a direct pathway to specialized science and healthcare careers, making them ideal for students seeking advancement without sacrificing current commitments.

Best Scientists Citing Yupo Ma

Trending Scientists

Recently Published Articles